Please note that in some countries (including but not limited to Belgium, France, Greece, Hungary, Ireland, Italy, Lithuania, Netherlands, Poland, Portugal, Romania, Singapore, Slovakia and Spain) promotion of medical devices to the general public violates the law. If you are not a medical specialist and access this website from one of these countries, you should leave this webpage as the content of this webpage may be prohibited by law according to the laws of your country of residence. If you ignore this warning, Elixir Medical assumes no liability for any consequences that may arise from accessing this information.

DESyne® X2


Corporate Headquarters
920 N. McCarthy Blvd.
Milpitas, CA 95035 U.S.

Elixir, Innovation for Life and DESyne are registered trademarks, and DynamX a trademark, in the US and internationally for Elixir Medical Corporation.
DynamX Coronary Bioadaptor System and DESyne X2 Novolimus Eluting Coronary Stent System are CE Mark approved.
©2020 Elixir Medical. All rights reserved.
International (OUS) Use Only. DynamX and DESyne X2 are intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

Sign up to receive news and information about Elixir Medical, our products and other relevant information as it becomes available.

Site designed by The Deciding Factor, Inc.